The Science Behind the Coronavirus, Series III: Mutations

5 240
1.7%
Published on 21 Jan 2021, 0:03
In the third installment of the Los Angeles Times series “The Science Behind the Coronavirus,” Dr. Patrick Soon-Shiong, the executive chairman of the Times, examines the pandemic’s latest threat: a second wave of global infections fueled by mutations to the virus. The multiple mutations resulting in these variants, Dr. Soon-Shiong explains, raise critical questions about the effectiveness of monoclonal antibodies, convalescent plasma and even antibody-based vaccines which have been designed to block the first wave of SARS-CoV-2.

Joining Dr. Soon-Shiong is Professor Tulio de Oliveira, a Brazilian-South African geneticist and bioinformatician who, along with a team of scientists, made the seminal discovery of the multiple mutations that gave rise to a contagious new variant in South Africa.

Dr. Patrick Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious disease. In mid-October, Soon-Shiong's company, ImmunityBio, received permission from the Food and Drug Administration to begin Phase 1 trials of its COVID-19 vaccine candidate. He has also received approval to begin trials in South Africa, where he will explore the potential of his T cell vaccine to prevent infection from these mutated virus strains.

SUBSCRIBE FOR MORE VIDEOS AND NEWS
youtube.com/subscription_cente...
latimes.com/subscription

LET’S CONNECT:
Facebook ► facebook.com/latimes
Twitter ► twitter.com/LATimes
Instagram ► instagram.com/latimes
newsautotechmusickids